Acknowledgement
Supported by : University Malaya
References
- Airley RE, Mobasheri A (2007). Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy, 53, 233-56. https://doi.org/10.1159/000104457
- Barretina J, Caponigro G, Stransky N, et al (2012). The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 483, 603-7. https://doi.org/10.1038/nature11003
- Chu IM, Hengst L, Slingerland JM (2008). The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nature Reviews Cancer, 8, 253-67. https://doi.org/10.1038/nrc2347
- Cooper G (2000). The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer Associates; 2000. Development and Causes of Cancer.
- Corrie PG (2008). Cytotoxic chemotherapy: clinical aspects. Med, 36, 24-8. https://doi.org/10.1016/j.mpmed.2007.10.012
- Deeb KK, Trump DL, Johnson CS (2007). Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nature Reviews Cancer, 7, 684-700. https://doi.org/10.1038/nrc2196
- Deng ZJ, Morton SW, Ben-Akiva E, et al (2013). Layer-bylayer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS nano, 7, 9571-84. https://doi.org/10.1021/nn4047925
- DeSantis CE, Lin CC, Mariotto AB, et al (2014). Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin, 64, 252-71. https://doi.org/10.3322/caac.21235
- Dong K, Liu Z, Li Z, et al (2013). Hydrophobic anticancer drug delivery by a 980 nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells In Vivo. Advanced Materials, 25, 4452-8. https://doi.org/10.1002/adma.201301232
- Fang RH, Hu C-MJ, Luk BT, et al (2014). Cancer cell membranecoated nanoparticles for anticancer vaccination and drug delivery. Nano letters, 14, 2181-8. https://doi.org/10.1021/nl500618u
- Foldbjerg R, Dang DA, Autrup H (2011). Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Archives of toxicol, 85, 743-50. https://doi.org/10.1007/s00204-010-0545-5
- Heiser LM, Sadanandam A, Kuo WL, et al (2012). Subtype and pathway specific responses to anticancer compounds in breast cancer. Proceedings National Academy Sci, 109, 2724-9. https://doi.org/10.1073/pnas.1018854108
- Homma S, Ishii Y, Morishima Y, et al (2009). Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res, 15, 3423-32. https://doi.org/10.1158/1078-0432.CCR-08-2822
- Kukowska-Latallo JF, Candido KA, Cao Z, et al (2005). Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res, 65, 5317-24. https://doi.org/10.1158/0008-5472.CAN-04-3921
- Kurai J, Chikumi H, Hashimoto K, et al (2007). Antibodydependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines. Clin Cancer Res, 13, 1552-61. https://doi.org/10.1158/1078-0432.CCR-06-1726
- Lopez-Lazaro M (2008). Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Molecular Nutrition Food Resea, 52, 103-27.
- Migliore L, Coppede F (2002). Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Research/Reviews Mutat Res, 512, 135-53. https://doi.org/10.1016/S1383-5742(02)00046-7
- Nagle DG, Zhou YD, Mora FD, et al (2004). Mechanism targeted discovery of antitumor marine natural products. Current Med Chem, 11, 1725. https://doi.org/10.2174/0929867043364991
- Pankova V, El-Shafei MAE-A, El-Fotouh E-MA, et al (2014). Cytotoxicity of trichoderma spp. cultural filtrate against human cervical and breast cancer cell lines. Asian Pac J Cancer Prev, 15, 7229-34. https://doi.org/10.7314/APJCP.2014.15.17.7229
- Park E-H, Kim Y-J, Yamabe N, et al (2014). Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell. J Ginseng Res, 38, 22-7. https://doi.org/10.1016/j.jgr.2013.11.007
- Pennati M, Lopergolo A, Profumo V, et al (2014). miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells. Biochemical Pharmacol, 87, 579-97. https://doi.org/10.1016/j.bcp.2013.12.009
- Rattan R, Graham RP, Maguire JL, et al (2011). Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia, 13, 483-28. https://doi.org/10.1593/neo.11148
- Sadikovic B, Al-Romaih K, Squire J, et al (2008). Cause and consequences of genetic and epigenetic alterations in human cancer. Current genomics, 9, 394. https://doi.org/10.2174/138920208785699580
- Schleich N, Sibret P, Danhier P, et al (2013). Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging. Int J Pharmaceutics, 447, 94-101. https://doi.org/10.1016/j.ijpharm.2013.02.042
- Siegel RL, Miller KD, Jemal A (2015). Cancer statistics, 2016. CA: A cancer journal for clinicians.
- Vanneman M, Dranoff G (2012). Combining immunotherapy and targeted therapies in cancer treatment. Nature Reviews Cancer, 12, 237-51. https://doi.org/10.1038/nrc3237
- Wang HQ, Li DL, Lu YJ, et al (2013). Anticancer activity of Acanthopanax trifoliatus (L) Merr extracts is associated with inhibition of NF-kB activity and decreased Erk1/2 and Akt phosphorylation. Asian Pacific J Cancer Prev, 15, 9341-6.